Serving microbiome innovators as the best-in-class CDMO means keeping our fingertips on the pulse of the industry. Discover what's new and what's next in this fast-moving field.
LATEST MICROBIOME INDUSTRY NEWS
JUNE 2021
Dispersal strategies shape persistence and evolution of human gut bacteria – Cell Host & Microbe
Microbial exposure during early human development primes fetal immune cells – Cell
Design of synthetic human gut microbiome assembly and butyrate production – Nature Communications
MAY 2021
Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis - Nature Communications
Host genetics, the microbiome & behaviour—a ‘Holobiont’ perspective – Nature, Cell Research
Reconstruction of ancient microbial genomes from the human gut – Nature
Fecal microbiota transplantation: can it circumvent resistance to PD-1 blockade in melanoma?
Piles of ancient poop reveal ‘extinction event’ in human gut bacteria – Science Magazine
Learn more about Arranta Bio and our commitment to microbiome innovators and the patients they serve by downloading our latest articles with interviews from our SMEs.
Read the latest press releases and news from Arranta Bio.
Reserve a copy of our upcoming white paper.
Videos, presentations, and interviews with our subject matter experts.
We're always open to engaging with individuals interested in our company or the microbiome therapy market in general.
We look forward to hearing from you.
Headquarters &
cGMP Manufacturing
650 Pleasant Street
Watertown, MA 02472
Process Development
& cGMP Manufacturing
1622 NW 55th Pl.
Gainesville, FL 32653
For CDMO Service Inquiries: bd@arrantabio.com
